What we know about GLP-1 medications in peri/menopausal women GLP-1 and GIP/GLP-1 receptor agonists have been extensively studied and consistently demonstrate substantial weight loss and cardiometabolic benefit in adults with overweight and obesity, including women across the adult lifespan
The National Agency for Food and Drug Administration and Control warned Nigerians about the circulation of an unauthorized and unregistered cancer drug, Darzalex (Daratumumab), in the country
Im not as bloated
[1] [2] This weekly dosing schedule is consistent with other agents in the incretin-based therapy class, such as semaglutide and tirzepatide, and is designed to maintain stable drug levels in the body throughout the treatment period
Blood pressure improvements are common, with systolic pressure dropping by 5 to 10 mmHg on average
The Ivm Health app included with the GLP-1 ID program helps you track these non-scale victories alongside your weight, providing a complete picture of your progress during maintenance